Robotic catheterization systems reduce radiation exposure by 95% and are set to grow at a 15% CAGR by 2029, driven by increased adoption and strategic mergers.
A recent clinical study radiation level research with robotic catheterization and normal cardiac intervention procedures reveals that robotic catheterization systems show reduction of ionizing radiation exposure by 95%. This factor will be prominent in pushing the preference for robotic catheterization systems as an effective procedure for catheterization. Projected to reach US$ 26 Mn by the end of 2019, robotic catheterization systems market is set to thrive at an impressive CAGR of 15% during the forecast period (2019 – 2029).
Interventional and surgical robotic systems have already made a significant impact on how surgeries are performed and are being increasingly adopted in modern operating rooms. Robotic catheterization systems have proved their abilities to perform interventional procedures with immensely low operator radiation exposure in comparison to the tradition catheterization procedures. Procedures where clinicians are given navigational and mechanical tools that permit definite actions or part of the procedure to be executed autonomously with a level of precession and control are possible only with robot-assisted catheterization.
Key Takeaways – Robotic Catheterization Systems Market Study
The first ever successful robotic PCI procedure in Asia Pacific that delivered positive results will be offering an inception point for the growth of robotic catheterization systems market in developing Asian economies.
Request Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9667
Market Leaders on Acquisition Spree
In reference to the trend in other medical device markets, key factors impacting the robotic catheterization systems market are partnerships and mergers observed in recent years. Key manufacturers are entering the robotic catheterization systems market by strategically expanding their reach through acquisitions and mergers, considering the increasing demand for these systems.
Product bundling of robotic catheterization and accessory systems at promotional rates and research contracts are forcing a decline in ASPs. Companies are focusing on limiting operational expenses to grow profitability. In contrast to these market changes, another significant factor influencing the robotic catheterization systems market is the exit and entrance of co-participating companies.
In August 2019, Corindus Vascular Robotics Inc., a prominent developer of precision vascular robotics, declared that it has settled on acquisition by Siemens Healthineers AG., representing a collective purchase price of approximately $1.1 billion. In April 2016, Hansen Medical Inc. was acquired by Auris Surgical Robotics Inc. in an arrangement with roughly US$ 80 Mn of equity value. With Hansen portfolio, Auris attained Magellan Robotic System, employed in navigating peripheral blood vessels in endovascular procedures, and Sensei Robotic System, a robotically steerable catheter system.
Looking for More Insights?
Robotic catheterization systems market, a new study from Future Market Insights, provides unparalleled insights on evolution of the robotic catheterization systems market during 2014 – 2018 and presents demand projections during 2019 – 2029 on the basis of product category (Electromechanical robotic catheterization systems, magnetic-guided robotic catheterization systems), application (percutaneous coronary intervention, cardiac electrophysiology procedures), and end user (hospitals, ambulatory surgical centers, catheterization laboratories) across seven prominent regions.
Any Queries, ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-9667
Table of Content
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3.1. Key Trends Impacting the Market
3.2. Product Development Trends
4.1. Install Base Scenario
4.2. Reimbursement Scenario
4.3. Regulatory Scenario
4.4. Prevalence of Cardiac Disorders, By Country
5.1. Historical Market Volume (Units) Analysis, 2014-2018
5.2. Current and Future Market Volume (Units) Projections, 2018-2028
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6.1. Regional Pricing Analysis By Product Type
6.2. Pricing Break-up
6.2.1. Manufacturer Level Pricing
6.2.2. Distributor Level Pricing
6.3. Global Average Pricing Analysis Benchmark
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com/
The article discusses the growth and opportunities in the global robotic catheterization systems market.
Robotic catheterization reduces ionizing radiation exposure by 95% and offers precise procedural control.
Increasing awareness, improved reimbursement scenarios, and strategic mergers influence market growth.
Explore more articles in the Research Reports category
